SEC 13F Intelligence

Managers / Q1 2026

Intesa Sanpaolo S.p.A.

CIK 0001374384 · PIAZZA SAN CARLO 156, TURIN, L6, 00000 · 39-011-555-1

Reported Value
$1.7B
Q1 2026
Positions
219
Filings on Record
3
2019–present window
Filed
May 15, 2026
original filing

Summary

Intesa Sanpaolo S.P.A. reported $1.7B in U.S.-listed holdings across 219 positions for Q1 2026.

Its largest position, Astrazeneca, represents 13.4% of the portfolio.

Compared with Q4 2025, the fund opened 34 new positions and exited 26.

Reported Value by Quarter

13F Reported Value
Q4 ’25: $1.7BQ4 ’25Q1 ’26: $1.7BQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 57.3%Other: 28.1%ETP: 13.3%ADR: 1.0%REIT: 0.3%
  • Common Stock · 57.3% · $970M
  • Other · 28.1% · $475M
  • ETP · 13.3% · $225M
  • ADR · 1.0% · $17M
  • REIT · 0.3% · $5M

Quarter-over-Quarter Changes full breakdown →

Holdings — Q1 2026

Loading…
Export to Excel
#IssuerClass% PortfolioValue ↓Shares

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$1.7B219May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$1.7B213Feb 17, 2026RESTATEMENTchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 8 additional managers.

  • Eurizon Capital SGR S.p.A.028-26161
  • Eurizon SLJ Capital Ltd028-26163
  • Eurizon Asset Management Slovakia, sprav. spol., a.s.028-26165
  • Eurizon Asset Management Hungary Ltd.028-26200
  • FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.028-26112
  • Fideuram Asset Management (Ireland) dac028-26159
  • Intesa Sanpaolo Wealth Management028-26256
  • VUB Generali dochodkova spravcovska spolocnost, a.s.028-26275

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.